Clinical Trial Update: Ticagrelor De-escalation Strategy in AMI Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating a ticagrelor de-escalation strategy in patients with acute myocardial infarction. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Dong-A University | Conditions: Acute Myocardial Infarction | Phase 4 | Status: RECRUITING